Recent Advances in High-throughput Platforms with Engineered Biomaterial Microarrays for Screening of Cell and Tissue Behavior

Author(s): Kijun Park, Yeontaek Lee, Jungmok Seo*.

Journal Name: Current Pharmaceutical Design

Volume 24 , Issue 45 , 2018

Submit Manuscript
Submit Proposal


In the last decades, bioengineers have developed myriad biomaterials for regenerative medicine. Development of screening techniques is essential for understanding complex behavior of cells in the biological microenvironments. Conventional approaches to the screening of cellular behavior in vitro have limitations in terms of accuracy, reusability, labor-intensive screening, and versatility. Thus, drug screening and toxicology test through in vitro screening platforms have been underwhelming. Recent advances in the high-throughput screening platforms somewhat overcome the limitations of in vitro screening platforms via repopulating human tissues’ biophysical and biomchemical microenvironments with the ability to continuous monitoring of miniaturized human tissue behavior. Herein, we review current trends in the screening platform in which a high-throughput system composed of engineered microarray devices is developed to investigate cell-biomaterial interaction. Furthermore, diverse methods to achieve continuous monitoring of cell behavior via developments of biosensor integrated high-throughput platforms, and future perspectives on high-throughput screening will be provided.

Keywords: High-throughput platforms, cell-biomaterial interactions, cellular microenvironments, biomaterial screening, organs-on-a-chip, myriad biomaterials.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [5458 - 5470]
Pages: 13
DOI: 10.2174/1381612825666190207093438
Price: $58

Article Metrics

PDF: 10